Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta‐analysis
Background and Aims Hepatocellular carcinoma (HCC) surveillance is associated with early
tumor detection and improved survival; however, it is often underused in clinical practice. We …
tumor detection and improved survival; however, it is often underused in clinical practice. We …
Experience with regorafenib in the treatment of hepatocellular carcinoma
A Granito, A Forgione, S Marinelli… - Therapeutic …, 2021 - journals.sagepub.com
Regorafenib is a diphenylurea oral multikinase inhibitor, structurally comparable to
sorafenib, which targets a variety of kinases implicated in angiogenic and tumor growth …
sorafenib, which targets a variety of kinases implicated in angiogenic and tumor growth …
The changing scenario of hepatocellular carcinoma in Italy: an update
F Garuti, A Neri, F Avanzato, A Gramenzi… - Liver …, 2021 - Wiley Online Library
Background and aims Epidemiology of hepatocellular carcinoma (HCC) is changing in most
areas of the world. This study aimed at updating the changing scenario of aetiology, clinical …
areas of the world. This study aimed at updating the changing scenario of aetiology, clinical …
[PDF][PDF] Patients with advanced hepatocellular carcinoma need a personalized management: a lesson from clinical practice
EG Giannini, L Bucci, F Garuti, M Brunacci… - …, 2018 - Wiley Online Library
The Barcelona Clinic Liver Cancer (BCLC) advanced stage (BCLC C) of hepatocellular
carcinoma (HCC) includes a heterogeneous population, where sorafenib alone is the …
carcinoma (HCC) includes a heterogeneous population, where sorafenib alone is the …
[HTML][HTML] Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological …
Purpose In 2015, we published a study on a small series of patients with hepatocellular
carcinoma (HCC) treated chronically with metformin for type II diabetes mellitus (DM2) who …
carcinoma (HCC) treated chronically with metformin for type II diabetes mellitus (DM2) who …
Patients with barcelona clinic liver cancer stages B and C hepatocellular carcinoma: time for a subclassification
R Golfieri, I Bargellini, C Spreafico, F Trevisani - Liver cancer, 2019 - karger.com
Abstract Background: The Barcelona Clinic Liver Cancer (BCLC) intermediate and
advanced stages (BCLC B and C) of hepatocellular carcinoma (HCC) both include …
advanced stages (BCLC B and C) of hepatocellular carcinoma (HCC) both include …
Development and validation of TACE refractoriness-related diagnostic and prognostic scores and characterization of tumor microenvironment infiltration in …
Q He, J Yang, Y Jin - Frontiers in immunology, 2022 - frontiersin.org
Background Transcatheter arterial chemoembolization LIHC, Liver hepatocellular
carcinoma;(TACE) is a valid therapeutic method for hepatocellular carcinoma (HCC) …
carcinoma;(TACE) is a valid therapeutic method for hepatocellular carcinoma (HCC) …
[HTML][HTML] New landscapes and horizons in hepatocellular carcinoma therapy
Hepatocellular carcinoma (HCC), is the sixth most frequent form of cancer and leads to the
fourth highest number of deaths each year. HCC results from a combination of …
fourth highest number of deaths each year. HCC results from a combination of …
The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: screening issue and future perspectives
In recent decades, non-alcoholic fatty liver disease (NAFLD) has become the most common
liver disease in the Western world, and the occurrence of its complications, such as …
liver disease in the Western world, and the occurrence of its complications, such as …
[HTML][HTML] Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma
Background/Objectives: Hepatocellular carcinoma (HCC) is a leading cause of cancer-
related mortality worldwide, primarily developing in the context of chronic liver disease …
related mortality worldwide, primarily developing in the context of chronic liver disease …